Navigation Links
Study shows major pain research funding decline at NIH
Date:12/11/2008

GLENVIEW, IL, Dec. 11, 2008 Federal funding for pain research is declining sharply, more than 9 percent a year since 2003, according to a new study published in The Journal of Pain. Pain research, as a result, now accounts for only 0.6 percent of all grants awarded by the National Institutes of Health (NIH), despite the high prevalence of chronic pain in the U.S.

"This startling finding shows the government's meager investment in pain research is seriously out of proportion with the widespread chronic pain incidence in our society, which is estimated at one in four Americans and accounts for more than 20 percent of all physician office visits," said Charles E. Inturrisi, president of the American Pain Society and professor of pharmacology at Weill Cornell Medical College, New York. "And this disparity is not attributable to years of budget cuts at NIH because the Journal of Pain study clearly shows pain research has a higher percentage decline than the overall NIH budget. So the drop in agency funding has not affected all research areas equally."

University of Utah researchers led by David H. Bradshaw, PhD of the university's pain research center, analyzed data about NIH grant awards from 2003 through 2007 for pain and compared pain research funding with dollars allocated for nausea and dyspnea, a breathing disorder. A previous study authored by Bradshaw, also published in The Journal of Pain in 2005, found that less than one percent of all NIH funding in 2003 was for research having a primary emphasis on pain. The current study shows that five years later pain research is still a low priority at NIH.

Noting that overall budget pressures in Washington have led to an unprecedented recession in funding for biomedical research, the authors said: "With decreased funding for research and continuing needs for resources to support national security and military efforts, major natural disasters and uncertain economic status, competition for limited research funds will intensify. The ability to track funding patterns becomes increasingly important for policy making decisions."

Inturrisi said APS has given financial support for the group's ongoing monitoring of NIH funding for pain research. "Our goal is to provide policy makers with an objective and verifiable classification tool for measuring grant awards and funding trends to help determine if NIH research dollars are being directed where the scientific and clinical need is most compelling," said Inturrisi. "Untreated and undertreated pain is the nation's most pervasive health problem and it's getting worse as the population ages. Pain research is the key for learning more about pain mechanisms and possible new treatments, but it is difficult to make significant progress if pain studies comprise just half of one percent of all NIH research grants," he added.

The study also reported that a review of all records for primary research for nausea and dyspnea, revealed that, unlike pain research funding trends, grants for those conditions increased steadily from 2003 to 2007. The authors concluded that even though there have been unprecedented funding cuts at NIH, "additional measures should be taken at NIH to improve the chances of funding for meritorious applications proposing research on pain."


'/>"/>

Contact: Chuck Weber
cpweber@weberpr.com
847-705-1802
American Pain Society
Source:Eurekalert

Related medicine news :

1. Womens magazines downplay emotional health risks of cosmetic surgery: UBC study
2. Study Asks: Are Physicians Overusing an Invasive Cardiac Treatment?
3. Study Questions Value of Anti-Meth Campaign
4. U.S. Department of Education Funded Study Demonstrates, WordWorld, a PBS KIDS(R) Television Series Works as Critical Early Literacy Tool
5. Success of anti-meth ads questioned by study
6. Study first to show that RNA interference can facilitate vaccine development
7. Study Suggests Sugar May Be Addictive
8. UC San Diego scientists developing brain imaging methods for studying natural human behavior
9. Study Showed New Episodes of Depression Delayed in People Taking Cymbalta(R)
10. Study finds selenium, vitamin E do not prevent prostate cancer
11. Study Finds Doctors Use of E-Prescribing Systems Linked to Formulary Data Can Boost Drug Cost Savings
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... ... 26, 2016 , ... PawPaws brand pet supplements owned by Whole ... enhance the health of felines. The formula is all-natural and is made from Chinese ... PawPaws Cat Kidney Support Supplement Soft Chews are Astragalus Root Extract and ...
(Date:6/26/2016)... Birmingham, Lake Orion, Clarkston, Michigan (PRWEB) , ... ... ... their direction with respect to fertility once they have been diagnosed with endometriosis. ... for tolerable intercourse but they also require a comprehensive approach that can help ...
(Date:6/25/2016)... ... ... Austin residents seeking Mohs surgery services, can now turn to Dr. Jessica ... Peckham for medical and surgical dermatology. , Dr. Dorsey brings specialization to include Mohs ... Mohs Micrographic Surgery completed by Dr. Dorsey was under the direction of Glenn Goldstein, ...
(Date:6/25/2016)... ... June 25, 2016 , ... "With 30 hand-drawn hand ... project," said Christina Austin - CEO of Pixel Film Studios. , ProHand Cartoon’s ... within Final Cut Pro X . Simply select a ProHand generator and drag ...
(Date:6/25/2016)... ... 25, 2016 , ... As a lifelong Southern Californian, Dr. Omkar Marathe earned ... the David Geffen School of Medicine at UCLA. He trained in Internal Medicine at ... fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai program where he had the opportunity ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... a startling report released today, National Safety Council research ... proven plan to eliminate prescription opioid overdoses. Prescription Nation ... tackling the worst drug crisis in recorded U.S. history, assigned a ... , New Mexico , Tennessee ... failing states, three – Michigan , ...
(Date:6/23/2016)... Research and Markets has announced the ... 2016 - Forecast to 2022" report to their offering. ... up to date financial data derived from varied research sources ... with potential impact on the market during the next five ... comprises of sub markets, regional and country level analysis. The ...
(Date:6/23/2016)... June 23, 2016 Research and Markets ... Issue 52" report to their offering. ... treatment creates a favourable commercial environment for MedImmune to enter. ... base that will serve to drive considerable growth for effective ... serve to cap sales considerably, but development is still in ...
Breaking Medicine Technology: